Actinium Pharmaceuticals, Inc Share Price

Actinium Pharmaceuticals, Inc Share Price

AMEX: ATNM | Micro Cap
$1.49
-$0.04 (-2.61%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Actinium Pharmaceuticals, Inc Stock Performance

Open
$1.50
Prev. Close
$1.53
Circuit Range
N/A
Day Range
$1.47 - $1.50
Year Range
$0.75 - $1.72
Volume
1,902
Average Traded
$1.49

Actinium Pharmaceuticals, Inc Share Price Today

As of 31 October 2026, Actinium Pharmaceuticals, Inc's share price is $1.49. The stock opened at $1.50, compared to its previous close of $1.53. During today's trading session, Actinium Pharmaceuticals, Inc's share price traded between $1.47 and $1.50, with an average price of $1.48. Over the past 52 weeks, the stock has recorded a high of $1.72 and a low of $0.75. In terms of performance, Actinium Pharmaceuticals, Inc's share price has risen by 33.04% over the last six months and is up 4.93% on a year-on-year basis.

Actinium Pharmaceuticals, Inc Share Price Chart

Line chart of the Actinium Pharmaceuticals, Inc price trend over the selected period. The price fell overall, ranging from 1.47 to 1.50, ending at 1.49.
$1.47$1.50
L
Show Current Price
H

Actinium Pharmaceuticals, Inc Stock Fundamentals & Key Indicators

Market Cap
$46.48M
PE Ratio (TTM)
4.25
Dividend Yield
0.00%
EPS (TTM)
$0.36
Revenue (TTM)
$90.00M
Return On Equity (TTM)
37.32%
Profit Margin
-37655.56%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
643.86%

Actinium Pharmaceuticals, Inc Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.09$0.00$0.00$35.00
Net Profit-$5.13-$5.94-$5.52$27.90
Net Profit Margin-5700.00%N/AN/A79.71%
Income ChangeN/A-15.79%7.07%605.43%

Actinium Pharmaceuticals, Inc Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.03$0.08$0.00$0.09
Net Profit-$33.02-$48.82-$38.24-$33.89
Net Profit Margin-3205.83%-61025.00%N/A-37655.56%
Income ChangeN/A-47.85%21.67%11.38%

About Actinium Pharmaceuticals, Inc

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Actinium Pharmaceuticals, Inc Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.15
$1.50
+30.43%
Sep 2026
$1.02
$1.15
+13.41%
Aug 2026
$0.85
$1.01
+20.71%
Jul 2026
$0.97
$0.84
-14.37%
Jun 2026
$1.21
$0.98
-21.83%
May 2026
$1.13
$1.25
+12.05%
Apr 2026
$0.99
$1.12
+14.05%
Mar 2026
$1.16
$0.98
-18.17%
Feb 2026
$1.22
$1.20
+3.45%
Jan 2026
$1.35
$1.16
-15.33%
Dec 2025
$1.39
$1.37
-2.49%
Nov 2025
$1.39
$1.41
-1.06%

ATNM Share Price FAQs